Global /Australia /Healthcare /Medical Devices /CYC

Cyclopharm Ltd.

CYC

• ASX: CYC • Delayed

0.7250AUD -2%

0.5174 USD

As of 5 June 2026, Cyclopharm Ltd. has a market cap of $66.57M USD, ranking #28485 globally and #682 in Australia. It ranks #2582 in the Healthcare sector, and #528 in the Medical Devices industry.

Global Rank

28485

Country Rank

682

Sector Rank

2582

Industry Rank

528

Key Stats

Market Cap

$66.57MUSD

93.29M AUD

Enterprise Value

$67.37MUSD

94.4M AUD

Revenue (TTM)

$23.07MUSD

32.33M AUD

EBITDA (TTM)

-$11.91MUSD

-16.69M AUD

Net Income (TTM)

-$12.29MUSD

-17.22M AUD

EBITDA Margin

-52%

Profit Margin

-53%

PS Ratio

2.9

PB Ratio

3.4

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

James McBrayer open_in_new

Employees

Founded

1986

Website

cyclomedica.com/company/cyclopharm/ open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2%	4.8%	1.3%	-38%	19%	-22%	-33%	-64%	-73%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	CYC Cyclopharm Ltd ISIN: AU000000CYC5 Shares Out.: Shares Outstanding: 126.066M¹ Shares Float: 64.815M² TV: TradingView: ASX: CYC SA: Stock Analysis: ASX: CYC YF: Yahoo Finance: CYC.AX GF: Google Finance: ASX: CYC BA: Barron's: CYC MS: Morningstar: XASX: CYC	0.7250 AUD	TV: TradingView: ASX: CYC SA: Stock Analysis: ASX: CYC YF: Yahoo Finance: CYC.AX GF: Google Finance: ASX: CYC BA: Barron's: CYC MS: Morningstar: XASX: CYC

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Cyclopharm Ltd.

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 6K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 4K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 1K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 1K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 157%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 156%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 260K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 241K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 239K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 190K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 181K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 153K%	22.2	Ireland

chevron_leftBack